Panagora Asset Management Inc Arbutus Biopharma Corp Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.01 - $3.42 $353 - $1,197	-350 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$0.87 - $2.89 $1,662 - $5,522	-1,911 Reduced 84.52%	350 $1,000
Q3 2019 Nov 12, 2019	SELL	$1.34 - $2.4 $40,632 - $72,775	-30,323 Reduced 93.06%	2,261 $3,000
Q2 2019 Aug 09, 2019	SELL	$1.46 - $4.44 $19,476 - $59,229	-13,340 Reduced 29.05%	32,584 $68,000
Q1 2019 May 15, 2019	SELL	$3.41 - $4.57 $88,574 - $118,705	-25,975 Reduced 36.13%	45,924 $164,000
Q4 2018 Feb 14, 2019	BUY	$3.5 - $9.66 $251,646 - $694,544	71,899 New	71,899 $275,000

155

99.5M

2.31M

525K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $478M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.